Vivos (RDGL) Change in Inventory (2010 - 2025)

Vivos (RDGL) posted Change in Inventory of -$5477.0 for Q4 2025, down 2312.78% sequentially from -$227.0 in Q3 2025.

Vivos (RDGL) Change in Inventory (2010 - 2025) Analysis & Trends

Vivos has reported Change in Inventory for 5 years, with the latest figure at -$5477.0 in Q4 2025.

Quarterly Change in Inventory changed N/A year-over-year to -$5477.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $57257.0 (changed N/A YoY) and the FY2025 annual result came in at $57257.0, changed N/A from the prior year.
Change in Inventory retreated to -$5477.0 in Q4 2025 per RDGL's latest filing, from -$227.0 in the prior quarter.
Over five years, Change in Inventory peaked at $41763.0 in Q2 2025 and troughed at -$5477.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	301.00 Mn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	113.00 Mn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	-399.00 Mn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	133.00 Mn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	23.50 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	36.40 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	139.00 Mn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	-131.35 Mn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	73.30 Mn
10	Vivos	24.08 Mn	22.53 Mn	-3,105.00	-5,477.00

Download Data